TRIANA Biomedicines is an emerging leader in the “molecular glue degrader” field with several potential best-in-class therapies for precision oncology.
Biotech
Details
- Founded
- 2019
- Partnered
- 2025
- Status
- Active
TRIANA Biomedicines is an emerging leader in the “molecular glue degrader” field with several potential best-in-class therapies for precision oncology.
Subscribe to get our research
the moment it’s released.
As compute costs fall and models mature, sustaining a competitive edge in global drug development requires innovation across the entire data infrastructure stack. Biology-native data, agentic workflows, and lab automation will define the next generation of leading biotechs.
What it takes to build generational AI companies in healthcare, life sciences, and beyond.
Investments in the commercialization of scientific research have propelled humanity forward—here are the businesses defining the deep technology category.
